Sie suchten nach: total bilirubin (Englisch - Maltesisch)

total bilirubin
aġġustament fid-doża

increased total bilirubin
Żieda fil-bilirubin totali

total bilirubin (mg/dl)
bilirubin totali (mg/dl)

total bilirubin > 5 x uln
bilirubina totali > 5 x uln

total bilirubin: = 1.5 uln
bilirubin totali: = 1.5 uln

phosphokinase increased total bilirubin
creatine phosphokinase għoli Żieda fil- bilirubin totali

total bilirubin: > 3-10 uln ast: any
bilirubin totali: > 3-10 uln ast: li jkun

high creatine phosphokinase increased total bilirubin
creatine phosphokinase għoli Żieda fil- bilirubin totali

the increase correlated with total bilirubin concentrations.
din iż-żieda kienet korrelata mal-livelli totali tal-konċentrazzjoni tal-bilirubin.

grade 3 or 4 elevation in ast, alt, or total bilirubin
elevazzjoni ta’ grad 3 jew 4 fl-ast, alt, jew il-bilirubina totali

hepatic transaminases increased, weight increased, total bilirubin increased*
Żieda ta’ transaminases epatiċi, Żieda fil-piż, Żieda fil-bilirubina totali

decreased total bilirubin, increased ggt, elevated plasma prolactin levels12.
jekk pazjent jiż viluppa sinjali u sintomi li huma indikattivi ta '

increases in transaminases or aminotransferase elevations accompanied by total bilirubin ≥ 2x uln
Ġew osservati żidiet fi transaminases jew żidiet f’aminotransferase akkumpanjati minn bilirubin totali

no clinically meaningful elevations in total bilirubin or alkaline phosphatase were observed.
ma kienet osservata l-ebda żieda klinikament sinifikanti fil-bilirubin totali jew fl- alkaline phosphatase.

the total bilirubin should be ≤ 1.5 times upper limit of normal.
it-total ta’ bilirubina għandu jkun ≤ 1.5 darbiet il-limitu massimu tan-normal.

the improvement in meld scores observed was driven largely by improvements in total bilirubin.
it-titjib osservat fil-punteġġi meld kien ikkawżat l-aktar minħabba titjib fil-bilirubina totali.

the total bilirubin should be ≤ 1.5-times upper limit of normal.
it-total ta’ bilirubina għandu jkun ta’ ≤ 1.5 il-limitu massimu tan-normal.

increased total bilirubin,b decreased absolute neutrophil count,b hypermagnesaemia,b, hypernatraemiab
żieda fil-bilirubin totali,b tnaqqis fl-għadd assolut ta’ newtrofili,b ipermagnesimja,b iponatremjab

patients with serum total bilirubin > 2.0 mg/dl were excluded from clinical studies.
pazjenti b’bilirubina totali fis-serum ta’ > 2.0 mg/dl ġew esklużi mill-istudji kliniċi.

increased serum concentrations of total bilirubin and aag concentrations were associated with a reduced erlotinib clearance.
Żieda fil-konċetrazzjonijiet fis-serum tat-total tal-bilirubina u konċetrazzjonijiet ta’ aag kienu assoċjati ma’ tnaqqis fit-tneħħija ta’ erlotinib.